Varying dosages of rifabutin affect white blood cell and platelet counts in human immunodeficiency virus--negative patients who are receiving multidrug regimens for pulmonary Mycobacterium avium complex disease.
Griffith
D E
DE
Department of Medicine, University of Texas Health Center, Tyler 75710, USA.
Brown
B A
BA
Wallace
R J
RJ
D017963:Azithromycin / Q000627:therapeutic use; D017291:Clarithromycin / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D006678:HIV; D006801:Humans; D007958:Leukocyte Count / Q000187:drug effects*; D008171:Lung Diseases / Q000188:drug therapy; D015269:Mycobacterium avium Complex; D015270:Mycobacterium avium-intracellulare Infection / Q000188:drug therapy*; D010976:Platelet Count / Q000187:drug effects*; D017828:Rifabutin / Q000627:therapeutic use*
D017828:Rifabutin; D017963:Azithromycin; D017291:Clarithromycin